ISSN 1662-4009 (online)

ey0017.9-8 | New Fertility Preservation Strategies: Lights and Shadows | ESPEYB17

9.8. Does co-transplantation of mesenchymal and spermatogonial stem cells improve reproductive efficiency and safety in mice?

P Kadam , E Ntemou , J Onofre , D Van Saen , E Goossens

To read the full abstract: Stem Cell Res Ther. 2019 Oct 22;10(1):310. ellen.goossens@vub.beInfertility due to spermatogonial stem cell (SSC) loss is one of the major late adverse effects related to both chemotherapy and radiotherapy, and several researchers are now focusing on the development of new techniques to preserve germ cells.Semen sample storage is not feasible in prepuber...

ey0016.6-16 | New Working Hypotheses in Transgender | ESPEYB16

6.16. Prevalence of the wish to be of the opposite gender in adolescents and adults with autism spectrum disorder

Miesen AIR van der , H Hurley , AM Bal , ALC de Vries

Arch Sex Behav. 2018 Nov;47(8):2307–2317.doi: 10.1007/s10508-018-1218-3. PubMed ID: 29736809An increased incidence of autism spectrum disorder (ASD) among adolescents and adults with gender dysphoria has been reported in many studies. This paper describes one of the rare studies taking an opposite approach, by investigating the self-reported wish to be of the ...

ey0016.15-8 | (1) | ESPEYB16

15.8. Variation in the heritability of child body mass index by obesogenic home environment

S Schrempft , CHM van Jaarsveld , A Fisher , M Herle , AD Smith , A Fildes , CH Llewellyn

To read the full abstract: JAMA Pediatr 2018;172:1153–1160.This paper describes a gene-environment interaction twin study in 925 UK families (1850 twins). The heritability of childhood BMI was calculated by comparing the concordance in BMI at mean age 4.1 years between monozygous and dizygous twins; heritability was much higher among more obesogenic households (h2=8...

ey0015.4-3 | Important for clinical practice | ESPEYB15

4.3 Cardiovascular risk factors and carotid intima media thickness in young adults born small for gestational age after cessation of growth hormone treatment: a 5-year longitudinal study

M van der Steen , GF Kerkhof , CCJ Smeets , ACS Hokken-Koelega

To read the full abstract: Lancet Diabetes Endocrinol 2017;5:975-985Whereas most SGA children experience spontaneous catch-up growth leading to the achievement of normal adult height, approximately 10% remain short and are candidates for GH therapy. SGA subjects have increased cardio-metabolic disease risk [17] and the effects of GH treatment on blood...

ey0015.6-8 | New treatments | ESPEYB15

6.8 Efficacy and Safety of Pubertal Induction Using 17β-Estradiol in Transgirls

SE Hannema , SEE Schagen , PT Cohen-Kettenis , HA Delemarre-van de Waal

To read the full abstract: J Clin Endocrinol Metab. 2017 Jul ;102 (7):2356-2363[Comments on 6.6, 6.7 and 6.8] These 3 papers deal with endocine pharmacological treatment of patients with GD.The first article by Chew et al. (6.6), from Australia, systematically reviews different pharmacolo...

ey0015.8-20 | Reviews | ESPEYB15

8.20 Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia

N1 Rensen , RJ Gemke , EC van Dalen , J Rotteveel , GJ Kaspers

To read the full abstract: Cochrane Database Syst Rev. 2017; 11:CD008727Glucocorticoids (GCs), such as prednisone (prednisolone) or dexamethasone, are essential agents in the treatment of acute lymphoblastic leukemia (ALL), the most common malignancy in childhood. They are administered in highly supraphysiologic doses in cyclic courses. Thus, every pediatric endocrinologist fears HPA axi...

ey0020.2-4 | Important for Clinical Practice | ESPEYB20

2.4. Childhood growth hormone treatment and metabolic and cardiovascular risk in adults born small for gestational age after growth hormone cessation in the Netherlands: a 12-year follow-up study

WJ Goedegebuure , M van der Steen , CCJ Smeets , ACS Hokken-Koelega

Brief summary: In this longitudinal study, the authors investigated the metabolic and cardiovascular health profile of 167 adults born SGA and previously treated with rhGH during a period of 12 years after therapy discontinuation. No relevant differences were found in treated SGA subjects compared with untreated SGA adults or adults born appropriate for gestational age (AGA), thus suggesting long-term metabolic and cardiovascular safety of rhGH treatment in short SGA children....

ey0020.4-12 | Changes to Growth Patterns | ESPEYB20

4.12. Just as tall on testosterone; a neutral to positive effect on adult height of GnRHa and testosterone in trans boys

LA Willemsen , LS Boogers , CM Wiepjes , DT Klink , ASP van Trotsenburg , M den Heijer , SE Hannema

Brief summary: This paper investigated the effect of pubertal suppression with GnRHa and gender affirming treatment with testosterone on the growth and final height of transgender boys. They found no negative effects, and even possibly a slight boost to adult height in comparison with target and predicted heights for birth-registered sex.One of the concerning features of transgender males is being able to identify with their cisgender peers in stature. I...

ey0020.4-14 | Longer Term Outcomes | ESPEYB20

4.14. Continuation of gender affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands

MATC van der Loos , SE Hannema , DT Klink , M den Heijer , CM Wiepjes

Brief summary: Concerns exist that transgender adolescents opting for gender affirming treatments may subsequently regret their decision. This large study from Amsterdam provides information that in early adulthood, 98% of their cohort continued to access these treatments.The Amsterdam Cohort of Gender Dysphoria is one of the largest ongoing studies on the long-term outcomes of gender affirming hormone treatments (GAH). The authors presented outcomes at ...

ey0020.12-8 | Steroids | ESPEYB20

12.8. Interpretation of steroid biomarkers in 21-hydroxylase deficiency and their use in disease management

K Sarafoglou , DP Merke , N Reisch , H Claahsen-van der Grinten , H Falhammar , RJ Auchus

Brief summary: In this Minireview, one pediatric and one adult case with 21-hydroxylase deficiency (21OHD) are discussed with respect to different clinical questions and steroid biomarkers reflecting their diagnosis, treatment and disease control. Basics of the disease mechanisms with different aspects throughout life (childhood, adulthood, sex, fertility and pregnancy) are discussed to lay grounds for the interpretation and use of laboratory data, including the newer 11-oxyge...